Opportunity
Blood Bank Sample Services
Response due
September 2, 2026
- Agency
- Dept of Commerce Nist
- Estimated value
- Not stated
The purpose of Amendment 0001 is as follows: 1. Update CLIN structure 2. Revise NTE unit quanity from 500 to 250 3. Update Statement of Work. 4. Provide response to industry questions 5. Extend due date for offers _______________________________________________________________________________________________________ The Biomolecular Measurement Division (BMD) of the Material Measurement Laboratory (MML) at the National Institute of Standards and Technology (NIST) mission is to provide measurement science,reference materials, reference data, and technologies to foster innovation and confidence in measurements needed to advance biotechnology, DNA forensics, biomedical and bioscience research, and health care. This supports the NIST mission by providing essential biological starting materials used for forensic DNA testing, Standard Reference Material (SRM) production, inter-laboratory studies, and the publication of allele frequencies.
Key dates
- Posted
- August 26, 2026
- Response due
- September 2, 2026
Who is this buyer
Organization
Buying history
- Records17 total
- Opportunities / awards0 / 5
- Value range$200,000 – $3,782,464
- ActiveAugust 11, 2026 – October 13, 2026
What they buy
- Clinical (17)
Set-asides used
- Small Business Set Aside - Total (11)
- No Set aside used (1)
Who holds their work today
- CHENEGA HEALTHCARE SERVICES LLC1 win · $3,782,464 · last January 1, 2019
- CHENEGA PRO FEDERAL SOLUTIONS, LLC1 win · $3,612,237 · last January 1, 2024
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 621511
- PSC
- 6550